Nevirapine not recommended for HIV postexposure prophylaxis Incidence study 09 February 2013 Pages: 21 - 21
Leuprorelin 30mg approved for prostate cancer in Canada Media release 09 February 2013 Pages: 22 - 22
Ubenimex: additional Japanese marketing application withdrawn News item 09 February 2013 Pages: 22 - 22